Award Timing Disclosure	12 Months Ended
Jul. 31, 2025
Award Timing Disclosures [Line Items]
Award Timing MNPI Disclosure [Text Block]	It is the Compensation Committee’s practice to consider and approve ordinary course annual equity grants for the Company’s executive officers at its regularly scheduled meeting held in September of each year. At this meeting, the Compensation Committee approves the portion of each named executive officer’s annual equity award that will be granted in the form of stock options, if any. The Company does not schedule its equity grants in anticipation of the release of material, non-public information (“MNPI”), nor does the Company time the release of MNPI based on equity grant dates. In the event MNPI becomes known to the Compensation Committee prior to granting an equity award, the Compensation Committee will take the existence of such information into consideration and use its collective business judgment to determine whether to delay the grant of equity to avoid any impropriety. During fiscal 2025, no named executive officer received a stock option grant during the period beginning four business days before, and ending one business day after, the filing of a periodic report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K that discloses MNPI.
Award Timing MNPI Considered [Flag]	false

Award Timing Disclosure

12 Months Ended

Jul. 31, 2025

Award Timing Disclosures [Line Items]

Award Timing MNPI Disclosure [Text Block]

It is the Compensation Committee’s practice to consider and approve ordinary course annual equity grants for the Company’s executive officers at its regularly scheduled meeting held in September of each year. At this meeting, the Compensation Committee approves the portion of each named executive officer’s annual equity award that will be granted in the form of stock options, if any.

The Company does not schedule its equity grants in anticipation of the release of material, non-public information (“MNPI”), nor does the Company time the release of MNPI based on equity grant dates. In the event MNPI becomes known to the Compensation Committee prior to granting an equity award, the Compensation Committee will take the existence of such information into consideration and use its collective business judgment to determine whether to delay the grant of equity to avoid any impropriety.

During fiscal 2025, no named executive officer received a stock option grant during the period beginning four business days before, and ending one business day after, the filing of a periodic report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K that discloses MNPI.

Award Timing MNPI Considered [Flag]

false